Vertex Pharmaceuticals Incorporated and Crinetics Pharmaceuticals, Inc. , a global pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for ...
Investor's Business Daily on MSN
Why this biotech, up 12% since its breakout, yo-yoed on a key FDA development
Pharvaris stock jumped early Monday, but closed down, after the FDA agreed to review the company's treatment for a serious ...
Crinetics adds potential best-in-class commercialized and Phase 3 endocrinology assets with ~$5 billion peak sales opportunity to Vertex's portfolio - PALSONIFY, Crinetics' recently launched, first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results